Subscribe to these results:

Upcoming Workshops

For All Cancers

  1. Register

For Breast Cancer

  1. Register
  2. Register
  3. Register

For Colorectal Cancer

  1. Register

For Gastrointestinal Stromal Tumors

  1. Register

For Lymphoma

  1. Register

For Mantle Cell Lymphoma

  1. Register

For Multiple Myeloma

  1. Register

Past workshops

For All Cancers

    1. Chemotherapy Treatment Side Effects: Prevention & Management
    2. Diverse Populations Participating in Decisions about Your Care with Your Health Care TeamPart II of How Health Care Disparities May Influence Your Cancer Treatment and Care
    3. Clinical Trials: How They Transform the Treatment of Cancer
    4. Managing the Side Effects of ImmunotherapyPart II of New Trends in Immunotherapy
    5. Understanding the Role of Immunotherapy in Treating CancerPart I of New Trends in Immunotherapy
    6. Understanding How Health Care Disparities May Influence Your Cancer Treatment and Care: With Tips & Strategies to Find the Best Cancer Treatment & Health Care Team for YouPart I of How Health Care Disparities May Influence Your Cancer Treatment and Care
    7. CAR T-Cell Therapy: What's New
    8. Preventing, Managing & Treating Infection in Adults Living with Cancer
    9. What’s New in Precision Medicine
    10. How Health Care Disparities May Influence Your Cancer Treatment & Care
    11. Understanding the Role of Immunotherapy in Treating CancerPart I of New Trends in Immunotherapy
    12. Taking Your Pills on Schedule: Why It Is So Important in Managing Cancer
    13. Emerging Importance of Telemedicine/Telehealth Appointments in Communicating with Your Health Care Team
    14. Cancer and Flu Shots
    15. Treatment Adherence: Taking Your Pills on Schedule – Why It Is So Important
    16. What are Biosimilars? Understanding Their Role in Cancer Treatment: Current and Future Perspectives
    17. Managing the Side Effects of ImmunotherapyPart II of New Trends in Immunotherapy
    18. Understanding the Role of Immunotherapy in Treating CancerPart I of New Trends in Immunotherapy
    19. Participating in Decisions about Your CarePart IV of Life with Cancer: A Guide to Getting the Best Care
    20. Understanding the Costs of Care and Your Health Care CoveragePart II of Life with Cancer: A Guide to Getting the Best Care
    21. Taking Your Treatment on Schedule: Its Importance in Managing Cancer
    22. Care for Your Bones During & After Cancer Treatment: Tips to Improve Bone Health
    23. Participating in Decisions about Your CarePart V of Life with Cancer: A Guide to Getting the Best Care
    24. Medical Emergencies in Cancer Treatment

For Acute Lymphoblastic Leukemia

    1. Chronic Lymphocytic Leukemia (CLL): Treatment Updates
    2. New Treatments for Childhood Acute Lymphocytic Leukemia (ALL)
    3. Progress in the Treatment of Non-Hodgkin Lymphoma (NHL)
    4. Adults Living with Acute Lymphocytic Leukemia (ALL): Treatment Updates
    5. Progress in the Treatment of Myelodysplastic Syndromes (MDS)
    6. Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
    7. Adjusting to Your Blood Cancer Treatment Over Time: Challenges and Opportunities of Taking Your Treatment on Schedule
    8. What’s New in Diagnostic Technologies for People Living with Blood CancersPart II of The Role of Diagnostic Technologies in Transforming the Treatment of People Living with Cancer
    9. Update from the 2021 American Society of Hematology (ASH) Annual Meeting
    10. Transplantation as a Treatment Option for Blood Cancers
    11. Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
    12. Adjusting to Your Blood Cancer Treatment Over Time: Challenges and Opportunities of Taking Your Treatment on Schedule
    13. Updates from the 2020 American Society of Hematology (ASH) Annual Meeting
    14. Update on CAR-T Cell Therapy
    15. Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
    16. Taking Your Blood Cancer Treatment on Schedule
    17. Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
    18. Treatment Update for Adults Living with Acute Lymphocytic Leukemia (ALL)
    19. New Treatments for Childhood Acute Lymphocytic Leukemia (ALL)

For Acute Myeloid Leukemia

    1. Chronic Lymphocytic Leukemia (CLL): Treatment Updates
    2. Progress in the Treatment of Non-Hodgkin Lymphoma (NHL)
    3. Adults Living with Acute Lymphocytic Leukemia (ALL): Treatment Updates
    4. Progress in the Treatment of Myelodysplastic Syndromes (MDS)
    5. Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
    6. Adjusting to Your Blood Cancer Treatment Over Time: Challenges and Opportunities of Taking Your Treatment on Schedule
    7. Acute Myeloid Leukemia (AML): Treatment Updates
    8. What’s New in Diagnostic Technologies for People Living with Blood CancersPart II of The Role of Diagnostic Technologies in Transforming the Treatment of People Living with Cancer
    9. Update from the 2021 American Society of Hematology (ASH) Annual Meeting
    10. Transplantation as a Treatment Option for Blood Cancers
    11. Update on the Treatment of Acute Myelogenous Leukemia (AML)
    12. Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
    13. Update on CAR T-Cell Therapies
    14. Adjusting to Your Blood Cancer Treatment Over Time: Challenges and Opportunities of Taking Your Treatment on Schedule
    15. Updates from the 2020 American Society of Hematology (ASH) Annual Meeting
    16. Living with Acute Myelogenous Leukemia (AML)
    17. Update on CAR-T Cell Therapy
    18. Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
    19. Taking Your Blood Cancer Treatment on Schedule
    20. Updates in the Treatment of Acute Myelogenous Leukemia
    21. Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches

For Basal Cell Cancer

    1. New Perspectives in the Treatment of Advanced Skin Cancer: Advanced Basal Cell and Squamous Cell Cancers
    2. New Perspectives in the Treatment of Advanced Skin Cancer: Advanced Basal Cell and Squamous Cell CancersPart I of Life with Advanced Skin Cancer

For Bladder Cancer

    1. Bladder Cancer: Treatment UpdatePart I of Life with Bladder Cancer
    2. Bladder Cancer: Treatment UpdatesPart I of Life with Bladder Cancer
    3. Update on the Treatment of Bladder CancerPart I of Living with Bladder Cancer
    4. What’s New in the Treatment of Bladder CancerPart I of Life with Bladder Cancer
    5. Updates on the Treatment of Bladder Cancer

For Bone Cancer

    1. Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches

For Brain Cancer

    1. Highlights from the 2022 American Society of Clinical Oncology (ASCO) Annual Meeting – “Advancing Equitable Cancer Care Through Innovation"Part I of Highlights from the 2022 ASCO Annual Meeting
    2. Glioblastoma in Adults: Treatment Updates
    3. Update on Glioblastoma in Adults
    4. Highlights from the 2020 American Society of Clinical Oncology (ASCO) Annual Meeting: Unite and Conquer: Accelerating Progress TogetherPart I of Your Guide to the Latest Cancer Research and Treatment
    5. Update on Glioblastoma in Adults

For Breast Cancer

    1. Metastatic Triple Negative Breast CancerPart I of Living with Metastatic Triple Negative Breast Cancer
    2. Metastatic Breast Cancer: Treatment Updates
    3. Highlights from the 2022 American Society of Clinical Oncology (ASCO) Annual Meeting – “Advancing Equitable Cancer Care Through Innovation"Part I of Highlights from the 2022 ASCO Annual Meeting
    4. HER2-Positive Metastatic Breast Cancer: What’s New in Treatment & Quality-of-Life
    5. The Role of Radiation Therapy in the Treatment of Breast Cancer
    6. Metastatic Breast Cancer in African Americans: New Treatments
    7. Updates in the Treatment of Estrogen Receptor (ER) Positive, Progesterone Receptor (PR) Positive and HER2 Positive Breast Cancer from the San Antonio Breast Cancer Symposium (SABCS)Part II of Living with Breast Cancer, with Updates from the San Antonio Breast Cancer Symposium (SABCS)
    8. Updates from the 44th Annual San Antonio Breast Cancer Symposium (SABCS) on Triple Negative Breast Cancer (TNBC)
    9. The Latest Developments Reported at the 44th Annual San Antonio Breast Cancer Symposium (SABCS)Part I of Living with Breast Cancer, with Updates from the San Antonio Breast Cancer Symposium (SABCS)
    10. Triple Negative Breast Cancer and African American Women
    11. HER2-Positive Metastatic Breast Cancer: New Therapies
    12. Metastatic Breast Cancer: Treatment Updates
    13. Highlights from the 2021 American Society of Clinical Oncology (ASCO) Annual MeetingPart I of Equity. Every Patient. Every Day. Everywhere.
    14. Updates on the Treatment of Estrogen Receptor (ER) Positive, Progesterone Receptor (PR) Positive & HER2 Positive Breast Cancer from the 43rd Annual San Antonio Breast Cancer Symposium (SABCS)Part II of Life with Breast Cancer - Updates from the 43rd Annual San Antonio Breast Cancer Symposium (SABCS)
    15. The Latest Developments Reported from the 43rd Annual San Antonio Breast Cancer Symposium (SABCS)Part I of Life with Breast Cancer - Updates from the 43rd Annual San Antonio Breast Cancer Symposium (SABCS)
    16. Updates from the San Antonio Breast Cancer Symposium (SABCS) on Triple Negative Breast Cancer (TNBC)
    17. Highlights from the 2020 American Society of Clinical Oncology (ASCO) Annual Meeting: Unite and Conquer: Accelerating Progress TogetherPart I of Your Guide to the Latest Cancer Research and Treatment
    18. Triple Negative Breast Cancer and African American Women
    19. What’s New in the Treatment of Breast Cancer for Women of All Ages
    20. What’s New in the Treatment of Metastatic Breast Cancer

For Cervical Cancer

    1. Highlights from the 2022 American Society of Clinical Oncology (ASCO) Annual Meeting – “Advancing Equitable Cancer Care Through Innovation"Part I of Highlights from the 2022 ASCO Annual Meeting
    2. Cervical Cancer: Treatment Advances

For Chronic Lymphocytic Leukemia

    1. Chronic Lymphocytic Leukemia (CLL): Treatment Updates
    2. Progress in the Treatment of Non-Hodgkin Lymphoma (NHL)
    3. Adults Living with Acute Lymphocytic Leukemia (ALL): Treatment Updates
    4. Progress in the Treatment of Myelodysplastic Syndromes (MDS)
    5. Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
    6. Adjusting to Your Blood Cancer Treatment Over Time: Challenges and Opportunities of Taking Your Treatment on Schedule
    7. Chronic Lymphocytic Leukemia: Current Treatment PerspectivesPart II of Living with Chronic Lymphocytic Leukemia
    8. Chronic Lymphocytic Leukemia: What's NewPart I of Living with Chronic Lymphocytic Leukemia
    9. What’s New in Diagnostic Technologies for People Living with Blood CancersPart II of The Role of Diagnostic Technologies in Transforming the Treatment of People Living with Cancer
    10. Update from the 2021 American Society of Hematology (ASH) Annual Meeting
    11. Transplantation as a Treatment Option for Blood Cancers
    12. Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
    13. Update on CAR T-Cell Therapies
    14. Current Perspectives on the Treatment of Chronic Lymphocytic Leukemia (CLL)Part II of Living with Chronic Lymphocytic Leukemia (CLL)
    15. Adjusting to Your Blood Cancer Treatment Over Time: Challenges and Opportunities of Taking Your Treatment on Schedule
    16. Update on Chronic Lymphocytic Leukemia (CLL)Part I of Living with Chronic Lymphocytic Leukemia (CLL)
    17. Updates from the 2020 American Society of Hematology (ASH) Annual Meeting
    18. Update on CAR-T Cell Therapy
    19. Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
    20. Current Perspectives on the Treatment of Relapsed/Refractory Chronic Lymphocytic Leukemia (CLL)Part II of Life with Chronic Lymphocytic Leukemia (CLL)
    21. Update on Chronic Lymphocytic LeukemiaPart I of Life with Chronic Lymphocytic Leukemia (CLL)
    22. Taking Your Blood Cancer Treatment on Schedule
    23. Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
    24. Life with CLL: Taking Charge of Your Treatment SchedulePart II of Life with Chronic Lymphocytic Leukemia (CLL)

For Chronic Myelogenous Leukemia

    1. Chronic Lymphocytic Leukemia (CLL): Treatment Updates
    2. Progress in the Treatment of Non-Hodgkin Lymphoma (NHL)
    3. Adults Living with Acute Lymphocytic Leukemia (ALL): Treatment Updates
    4. Progress in the Treatment of Myelodysplastic Syndromes (MDS)
    5. Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
    6. Adjusting to Your Blood Cancer Treatment Over Time: Challenges and Opportunities of Taking Your Treatment on Schedule
    7. What’s New in Diagnostic Technologies for People Living with Blood CancersPart II of The Role of Diagnostic Technologies in Transforming the Treatment of People Living with Cancer
    8. Update from the 2021 American Society of Hematology (ASH) Annual Meeting
    9. Transplantation as a Treatment Option for Blood Cancers
    10. Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
    11. Update on CAR T-Cell Therapies
    12. Adjusting to Your Blood Cancer Treatment Over Time: Challenges and Opportunities of Taking Your Treatment on Schedule
    13. Updates from the 2020 American Society of Hematology (ASH) Annual Meeting
    14. Living with Chronic Myelogenous Leukemia (CML)
    15. Update on CAR-T Cell Therapy
    16. Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
    17. Taking Your Blood Cancer Treatment on Schedule
    18. Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches

For Colorectal Cancer

    1. Highlights from the 2022 American Society of Clinical Oncology (ASCO) Annual Meeting - "Advancing Equitable Cancer Care Through Innovation"Part II of Highlights from the 2022 ASCO Annual Meeting
    2. Colorectal Cancer Treatment: Progress and Advances
    3. Colorectal Cancer Treatment: Progress & Advances
    4. Highlights from the 2021 American Society of Clinical Oncology (ASCO) Annual MeetingPart II of Equity. Every Patient. Every Day. Everywhere.
    5. Advances in the Treatment of Colorectal Cancer
    6. Progress in the Treatment of Colorectal Cancer

For Cutaneous T-Cell Lymphoma

    1. Update On Marginal Zone Lymphoma (MZL)
    2. Waldenstrom’s Macroglobulinemia (WM): Treatment Progress
    3. Progress in the Treatment of Non-Hodgkin Lymphoma (NHL)
    4. Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
    5. Adjusting to Your Blood Cancer Treatment Over Time: Challenges and Opportunities of Taking Your Treatment on Schedule
    6. What’s New in Diagnostic Technologies for People Living with Blood CancersPart II of The Role of Diagnostic Technologies in Transforming the Treatment of People Living with Cancer
    7. Update from the 2021 American Society of Hematology (ASH) Annual Meeting
    8. Transplantation as a Treatment Option for Blood Cancers
    9. Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
    10. Update on Diffuse Large B-Cell Lymphoma (DLBCL)
    11. Update on CAR T-Cell Therapies
    12. Adjusting to Your Blood Cancer Treatment Over Time: Challenges and Opportunities of Taking Your Treatment on Schedule
    13. Updates from the 2020 American Society of Hematology (ASH) Annual Meeting
    14. Update on CAR-T Cell Therapy
    15. Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
    16. Taking Your Blood Cancer Treatment on Schedule
    17. Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
    18. The Emerging Role of Immunotherapy in the Treatment of Lymphoma

For Diffuse Large B-Cell Lymphoma

    1. Update On Marginal Zone Lymphoma (MZL)
    2. Waldenstrom’s Macroglobulinemia (WM): Treatment Progress
    3. Progress in the Treatment of Non-Hodgkin Lymphoma (NHL)
    4. Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
    5. Adjusting to Your Blood Cancer Treatment Over Time: Challenges and Opportunities of Taking Your Treatment on Schedule
    6. Diffuse Large B-Cell Lymphoma (DLBCL) Updates
    7. What’s New in Diagnostic Technologies for People Living with Blood CancersPart II of The Role of Diagnostic Technologies in Transforming the Treatment of People Living with Cancer
    8. Update from the 2021 American Society of Hematology (ASH) Annual Meeting
    9. Update on Diffuse Large B-Cell Lymphoma (DLBCL)
    10. Update on CAR T-Cell Therapies
    11. Adjusting to Your Blood Cancer Treatment Over Time: Challenges and Opportunities of Taking Your Treatment on Schedule
    12. Updates from the 2020 American Society of Hematology (ASH) Annual Meeting
    13. Update on Diffuse Large B-Cell Lymphoma (DLBCL)
    14. Update on CAR-T Cell Therapy
    15. Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
    16. Taking Your Blood Cancer Treatment on Schedule
    17. Update on Diffuse Large B-Cell Lymphoma
    18. Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
    19. The Emerging Role of Immunotherapy in the Treatment of Lymphoma

For Endometrial Cancer

    1. Update on the Treatment of Endometrial Cancer

For Follicular Lymphoma

    1. Update On Marginal Zone Lymphoma (MZL)
    2. Waldenstrom’s Macroglobulinemia (WM): Treatment Progress
    3. Progress in the Treatment of Non-Hodgkin Lymphoma (NHL)
    4. Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
    5. Adjusting to Your Blood Cancer Treatment Over Time: Challenges and Opportunities of Taking Your Treatment on Schedule
    6. Follicular Lymphoma: Treatment Progress
    7. What’s New in Diagnostic Technologies for People Living with Blood CancersPart II of The Role of Diagnostic Technologies in Transforming the Treatment of People Living with Cancer
    8. Update from the 2021 American Society of Hematology (ASH) Annual Meeting
    9. Transplantation as a Treatment Option for Blood Cancers
    10. Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
    11. Update on Diffuse Large B-Cell Lymphoma (DLBCL)
    12. Update on CAR T-Cell Therapies
    13. Adjusting to Your Blood Cancer Treatment Over Time: Challenges and Opportunities of Taking Your Treatment on Schedule
    14. Progress in the Treatment of Follicular Lymphoma
    15. Updates from the 2020 American Society of Hematology (ASH) Annual Meeting
    16. Update on CAR-T Cell Therapy
    17. Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
    18. Taking Your Blood Cancer Treatment on Schedule
    19. Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
    20. The Emerging Role of Immunotherapy in the Treatment of Lymphoma

For Gastric Cancer

    1. Gastric Cancer: Treatment Advances
    2. Gastric Cancer: Treatment Updates
    3. Advances in the Treatment of Gastric Cancer
    4. Advances in the Treatment of Gastric Cancer
    5. Current Perspectives in the Treatment of Metastatic Gastric Cancer

For Gastrointestinal Stromal Tumors

    1. Gastric Cancer: Treatment Advances
    2. Advances in the Treatment of Gastrointestinal Stromal Tumors (GIST)

For Glioblastoma

    1. Highlights from the 2022 American Society of Clinical Oncology (ASCO) Annual Meeting – “Advancing Equitable Cancer Care Through Innovation"Part I of Highlights from the 2022 ASCO Annual Meeting
    2. Glioblastoma in Adults: Treatment Updates
    3. Highlights from the 2021 American Society of Clinical Oncology (ASCO) Annual MeetingPart I of Equity. Every Patient. Every Day. Everywhere.
    4. Update on Glioblastoma in Adults
    5. Highlights from the 2020 American Society of Clinical Oncology (ASCO) Annual Meeting: Unite and Conquer: Accelerating Progress TogetherPart I of Your Guide to the Latest Cancer Research and Treatment
    6. Update on Glioblastoma in Adults

For Head and Neck Cancer

    1. Oral, Head & Neck Cancer: Treatment Update
    2. Highlights from the 2021 American Society of Clinical Oncology (ASCO) Annual MeetingPart I of Equity. Every Patient. Every Day. Everywhere.
    3. Treatment Update in Oral and Head and Neck Cancer
    4. Highlights from the 2020 American Society of Clinical Oncology (ASCO) Annual Meeting: Unite and Conquer: Accelerating Progress TogetherPart I of Your Guide to the Latest Cancer Research and Treatment
    5. What’s New in the Treatment of Oral and Head and Neck Cancer

For Hodgkin Lymphoma

    1. Update On Marginal Zone Lymphoma (MZL)
    2. Waldenstrom’s Macroglobulinemia (WM): Treatment Progress
    3. Progress in the Treatment of Non-Hodgkin Lymphoma (NHL)
    4. Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
    5. Adjusting to Your Blood Cancer Treatment Over Time: Challenges and Opportunities of Taking Your Treatment on Schedule
    6. What’s New in Diagnostic Technologies for People Living with Blood CancersPart II of The Role of Diagnostic Technologies in Transforming the Treatment of People Living with Cancer
    7. Update from the 2021 American Society of Hematology (ASH) Annual Meeting
    8. Transplantation as a Treatment Option for Blood Cancers
    9. Progress in the Treatment of Non-Hodgkin Lymphoma (NHL)
    10. Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
    11. Update on Diffuse Large B-Cell Lymphoma (DLBCL)
    12. Update on CAR T-Cell Therapies
    13. Progress in the Treatment of Waldenstrom’s Macroglobulinemia (WM)
    14. Adjusting to Your Blood Cancer Treatment Over Time: Challenges and Opportunities of Taking Your Treatment on Schedule
    15. Updates from the 2020 American Society of Hematology (ASH) Annual Meeting
    16. What’s New in the Treatment of Hodgkin Lymphoma
    17. Update on CAR-T Cell Therapy
    18. Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
    19. Taking Your Blood Cancer Treatment on Schedule
    20. Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
    21. The Emerging Role of Immunotherapy in the Treatment of Lymphoma

For Kidney Cancer

    1. Renal Cell Cancer: Treatment Advances
    2. Advances in the Treatment of Renal Cell Cancer

For Leukemia

    1. Chronic Lymphocytic Leukemia (CLL): Treatment Updates
    2. Highlights from the 2022 American Society of Clinical Oncology (ASCO) Annual Meeting - "Advancing Equitable Cancer Care Through Innovation"Part II of Highlights from the 2022 ASCO Annual Meeting
    3. New Treatments for Childhood Acute Lymphocytic Leukemia (ALL)
    4. Progress in the Treatment of Non-Hodgkin Lymphoma (NHL)
    5. Adults Living with Acute Lymphocytic Leukemia (ALL): Treatment Updates
    6. Progress in the Treatment of Myelodysplastic Syndromes (MDS)
    7. Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
    8. Adjusting to Your Blood Cancer Treatment Over Time: Challenges and Opportunities of Taking Your Treatment on Schedule
    9. Acute Myeloid Leukemia (AML): Treatment Updates
    10. Chronic Lymphocytic Leukemia: Current Treatment PerspectivesPart II of Living with Chronic Lymphocytic Leukemia
    11. Chronic Lymphocytic Leukemia: What's NewPart I of Living with Chronic Lymphocytic Leukemia
    12. What’s New in Diagnostic Technologies for People Living with Blood CancersPart II of The Role of Diagnostic Technologies in Transforming the Treatment of People Living with Cancer
    13. Update from the 2021 American Society of Hematology (ASH) Annual Meeting
    14. Highlights from the 2021 American Society of Clinical Oncology (ASCO) Annual MeetingPart II of Equity. Every Patient. Every Day. Everywhere.
    15. Transplantation as a Treatment Option for Blood Cancers
    16. Progress in the Treatment of Myelofibrosis
    17. Update on the Treatment of Acute Myelogenous Leukemia (AML)
    18. Update on CAR T-Cell Therapies
    19. Current Perspectives on the Treatment of Chronic Lymphocytic Leukemia (CLL)Part II of Living with Chronic Lymphocytic Leukemia (CLL)
    20. Adjusting to Your Blood Cancer Treatment Over Time: Challenges and Opportunities of Taking Your Treatment on Schedule
    21. Update on Chronic Lymphocytic Leukemia (CLL)Part I of Living with Chronic Lymphocytic Leukemia (CLL)
    22. Updates from the 2020 American Society of Hematology (ASH) Annual Meeting
    23. Living with Acute Myelogenous Leukemia (AML)
    24. Progress in the Treatment of Myelodysplastic Syndrome (MDS)
    25. Living with Chronic Myelogenous Leukemia (CML)
    26. Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
    27. Current Perspectives on the Treatment of Relapsed/Refractory Chronic Lymphocytic Leukemia (CLL)Part II of Life with Chronic Lymphocytic Leukemia (CLL)
    28. Update on Chronic Lymphocytic LeukemiaPart I of Life with Chronic Lymphocytic Leukemia (CLL)
    29. Taking Your Blood Cancer Treatment on Schedule
    30. Updates in the Treatment of Acute Myelogenous Leukemia
    31. Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
    32. Treatment Update for Adults Living with Acute Lymphocytic Leukemia (ALL)
    33. Life with CLL: Taking Charge of Your Treatment SchedulePart II of Life with Chronic Lymphocytic Leukemia (CLL)
    34. New Treatments for Childhood Acute Lymphocytic Leukemia (ALL)

For Liver Cancer

    1. Liver Cancer: Treatment Updates
    2. Liver Cancer: Treatment Updates
    3. Treatment Update on Liver Cancer

For Lung Cancer

    1. Highlights from the 2022 American Society of Clinical Oncology (ASCO) Annual Meeting - "Advancing Equitable Cancer Care Through Innovation"Part II of Highlights from the 2022 ASCO Annual Meeting
    2. Genomic Testing and Current Trends in the Treatment of Non-Small Cell Lung CancerPart III of Living with Non-Small Cell Lung Cancer
    3. Small Cell Lung Cancer: Treatment UpdatePart I of Living with Small Cell Lung Cancer
    4. Non-Small Cell Lung Cancer: Treatment AdvancesPart I of Living with Non-Small Cell Lung Cancer
    5. Non-Small Cell Lung Cancer: What’s NewPart I of Living with Non-Small Cell Lung Cancer
    6. Highlights from the 2021 American Society of Clinical Oncology (ASCO) Annual MeetingPart II of Equity. Every Patient. Every Day. Everywhere.
    7. Diverse Populations Living with Non-Small Cell Lung Cancer
    8. Advances in the Treatment of Lung CancerPart I of Living with Lung Cancer
    9. Update on Small Cell Lung Cancer Treatments
    10. For Caregivers: Practical Tips for Coping with Your Loved One’s Lung CancerPart II of Living with Lung Cancer
    11. Progress in the Treatment of Lung CancerPart I of Living with Lung Cancer
    12. Advances in the Treatment of Lung CancerPart I of Life with Lung Cancer
    13. For Caregivers: Practical Tips for Coping with Your Loved One’s Lung Cancer During the HolidaysPart II of Life with Lung Cancer
    14. Progress in the Treatment of Lung CancerPart I of Life with Lung Cancer

For Lymphoma

    1. Highlights from the 2022 American Society of Clinical Oncology (ASCO) Annual Meeting - "Advancing Equitable Cancer Care Through Innovation"Part II of Highlights from the 2022 ASCO Annual Meeting
    2. Update On Marginal Zone Lymphoma (MZL)
    3. Waldenstrom’s Macroglobulinemia (WM): Treatment Progress
    4. Progress in the Treatment of Non-Hodgkin Lymphoma (NHL)
    5. Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
    6. Adjusting to Your Blood Cancer Treatment Over Time: Challenges and Opportunities of Taking Your Treatment on Schedule
    7. Mantle Cell Lymphoma: Treatment UpdatePart I of Living with Mantle Cell Lymphoma (MCL)
    8. Follicular Lymphoma: Treatment Progress
    9. Diffuse Large B-Cell Lymphoma (DLBCL) Updates
    10. Marginal Zone Lymphoma (MZL): Treatment Updates
    11. What’s New in Diagnostic Technologies for People Living with Blood CancersPart II of The Role of Diagnostic Technologies in Transforming the Treatment of People Living with Cancer
    12. Update from the 2021 American Society of Hematology (ASH) Annual Meeting
    13. Highlights from the 2021 American Society of Clinical Oncology (ASCO) Annual MeetingPart II of Equity. Every Patient. Every Day. Everywhere.
    14. Transplantation as a Treatment Option for Blood Cancers
    15. Update on Marginal Zone Lymphoma (MZL)
    16. Progress in the Treatment of Non-Hodgkin Lymphoma (NHL)
    17. Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
    18. Update on Diffuse Large B-Cell Lymphoma (DLBCL)
    19. Update on CAR T-Cell Therapies
    20. Progress in the Treatment of Waldenstrom’s Macroglobulinemia (WM)
    21. Treatment Update on Mantle Cell Lymphoma (MCL)Part I of Living with Mantle Cell Lymphoma
    22. Adjusting to Your Blood Cancer Treatment Over Time: Challenges and Opportunities of Taking Your Treatment on Schedule
    23. Progress in the Treatment of Follicular Lymphoma
    24. Updates from the 2020 American Society of Hematology (ASH) Annual Meeting
    25. Update on Diffuse Large B-Cell Lymphoma (DLBCL)
    26. New Perspectives in the Treatment of Peripheral T-Cell Lymphoma (PTCL)
    27. What’s New in the Treatment of Hodgkin Lymphoma
    28. Treatment Update on Mantle Cell Lymphoma (MCL)
    29. Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
    30. Progress in the Treatment of Non-Hodgkin Lymphoma (NHL)
    31. Taking Your Blood Cancer Treatment on Schedule
    32. The Latest News in the Treatment of Waldenstrom’s Macroglobulinemia (WM)
    33. Update on Diffuse Large B-Cell Lymphoma
    34. Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
    35. The Emerging Role of Immunotherapy in the Treatment of Lymphoma

For Mantle Cell Lymphoma

    1. Update On Marginal Zone Lymphoma (MZL)
    2. Waldenstrom’s Macroglobulinemia (WM): Treatment Progress
    3. Progress in the Treatment of Non-Hodgkin Lymphoma (NHL)
    4. Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
    5. Adjusting to Your Blood Cancer Treatment Over Time: Challenges and Opportunities of Taking Your Treatment on Schedule
    6. Mantle Cell Lymphoma: Treatment UpdatePart I of Living with Mantle Cell Lymphoma (MCL)
    7. What’s New in Diagnostic Technologies for People Living with Blood CancersPart II of The Role of Diagnostic Technologies in Transforming the Treatment of People Living with Cancer
    8. Update from the 2021 American Society of Hematology (ASH) Annual Meeting
    9. Progress in the Treatment of Non-Hodgkin Lymphoma (NHL)
    10. Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
    11. Update on Diffuse Large B-Cell Lymphoma (DLBCL)
    12. Update on CAR T-Cell Therapies
    13. Progress in the Treatment of Waldenstrom’s Macroglobulinemia (WM)
    14. Treatment Update on Mantle Cell Lymphoma (MCL)Part I of Living with Mantle Cell Lymphoma
    15. Adjusting to Your Blood Cancer Treatment Over Time: Challenges and Opportunities of Taking Your Treatment on Schedule
    16. Updates from the 2020 American Society of Hematology (ASH) Annual Meeting
    17. Treatment Update on Mantle Cell Lymphoma (MCL)
    18. Update on CAR-T Cell Therapy
    19. Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
    20. Taking Your Blood Cancer Treatment on Schedule
    21. Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
    22. The Emerging Role of Immunotherapy in the Treatment of Lymphoma

For Marginal Zone Lymphoma

    1. Update On Marginal Zone Lymphoma (MZL)
    2. Waldenstrom’s Macroglobulinemia (WM): Treatment Progress
    3. Progress in the Treatment of Non-Hodgkin Lymphoma (NHL)
    4. Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
    5. Adjusting to Your Blood Cancer Treatment Over Time: Challenges and Opportunities of Taking Your Treatment on Schedule
    6. Marginal Zone Lymphoma (MZL): Treatment Updates
    7. What’s New in Diagnostic Technologies for People Living with Blood CancersPart II of The Role of Diagnostic Technologies in Transforming the Treatment of People Living with Cancer
    8. Update from the 2021 American Society of Hematology (ASH) Annual Meeting
    9. Update on Marginal Zone Lymphoma (MZL)
    10. Progress in the Treatment of Non-Hodgkin Lymphoma (NHL)
    11. Update on Diffuse Large B-Cell Lymphoma (DLBCL)
    12. Update on CAR T-Cell Therapies
    13. Progress in the Treatment of Waldenstrom’s Macroglobulinemia (WM)
    14. Adjusting to Your Blood Cancer Treatment Over Time: Challenges and Opportunities of Taking Your Treatment on Schedule
    15. Updates from the 2020 American Society of Hematology (ASH) Annual Meeting
    16. Update on CAR-T Cell Therapy
    17. Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
    18. Taking Your Blood Cancer Treatment on Schedule
    19. Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
    20. The Emerging Role of Immunotherapy in the Treatment of Lymphoma

For Melanoma

    1. Highlights from the 2022 American Society of Clinical Oncology (ASCO) Annual Meeting - "Advancing Equitable Cancer Care Through Innovation"Part II of Highlights from the 2022 ASCO Annual Meeting
    2. People of Color Living with Skin Cancer
    3. Emerging Treatments for Metastatic MelanomaPart II of Living with Advanced Skin Cancer and Melanoma
    4. Highlights from the 2021 American Society of Clinical Oncology (ASCO) Annual MeetingPart II of Equity. Every Patient. Every Day. Everywhere.
    5. Emerging Treatments for Metastatic MelanomaPart II of Living with Advanced Skin Cancer and Melanoma
    6. New Perspectives in the Treatment of Advanced Skin Cancer: Advanced Basal Cell and Squamous Cell CancersPart I of Living with Advanced Skin Cancer and Melanoma
    7. Emerging Treatments for Metastatic MelanomaPart II of Life with Advanced Skin Cancer

For Merkel Cell Carcinoma

    1. Emerging Treatments for Metastatic MelanomaPart II of Living with Advanced Skin Cancer and Melanoma
    2. Treatment Perspectives on Merkel Cell Carcinoma (MCC)Part I of Living with Merkel Cell Carcinoma (MCC)

For Mesothelioma

    1. Mesothelioma: Innovative Treatment Options
    2. Mesothelioma: Innovative Treatment Options
    3. Advances in the Treatment of Mesothelioma

For Metastatic Breast Cancer

    1. Metastatic Triple Negative Breast CancerPart I of Living with Metastatic Triple Negative Breast Cancer
    2. Metastatic Breast Cancer: Treatment Updates
    3. HER2-Positive Metastatic Breast Cancer: What’s New in Treatment & Quality-of-Life
    4. The Role of Radiation Therapy in the Treatment of Breast Cancer
    5. Metastatic Breast Cancer in African Americans: New Treatments
    6. Updates in the Treatment of Estrogen Receptor (ER) Positive, Progesterone Receptor (PR) Positive and HER2 Positive Breast Cancer from the San Antonio Breast Cancer Symposium (SABCS)Part II of Living with Breast Cancer, with Updates from the San Antonio Breast Cancer Symposium (SABCS)
    7. Updates from the 44th Annual San Antonio Breast Cancer Symposium (SABCS) on Triple Negative Breast Cancer (TNBC)
    8. The Latest Developments Reported at the 44th Annual San Antonio Breast Cancer Symposium (SABCS)Part I of Living with Breast Cancer, with Updates from the San Antonio Breast Cancer Symposium (SABCS)
    9. HER2-Positive Metastatic Breast Cancer: New Therapies
    10. Metastatic Breast Cancer: Treatment Updates
    11. Highlights from the 2021 American Society of Clinical Oncology (ASCO) Annual MeetingPart I of Equity. Every Patient. Every Day. Everywhere.
    12. Updates on the Treatment of Estrogen Receptor (ER) Positive, Progesterone Receptor (PR) Positive & HER2 Positive Breast Cancer from the 43rd Annual San Antonio Breast Cancer Symposium (SABCS)Part II of Life with Breast Cancer - Updates from the 43rd Annual San Antonio Breast Cancer Symposium (SABCS)
    13. The Latest Developments Reported from the 43rd Annual San Antonio Breast Cancer Symposium (SABCS)Part I of Life with Breast Cancer - Updates from the 43rd Annual San Antonio Breast Cancer Symposium (SABCS)
    14. Updates from the San Antonio Breast Cancer Symposium (SABCS) on Triple Negative Breast Cancer (TNBC)
    15. Highlights from the 2020 American Society of Clinical Oncology (ASCO) Annual Meeting: Unite and Conquer: Accelerating Progress TogetherPart I of Your Guide to the Latest Cancer Research and Treatment
    16. Triple Negative Breast Cancer and African American Women
    17. What’s New in the Treatment of Breast Cancer for Women of All Ages
    18. What’s New in the Treatment of Metastatic Breast Cancer

For Multiple Myeloma

    1. Progress in the Treatment of Multiple Myeloma
    2. Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
    3. Adjusting to Your Blood Cancer Treatment Over Time: Challenges and Opportunities of Taking Your Treatment on Schedule
    4. Coping with the Stresses of Caregiving When Your Loved One Has Multiple MyelomaPart II of Living with Multiple Myeloma
    5. What’s New in Diagnostic Technologies for People Living with Blood CancersPart II of The Role of Diagnostic Technologies in Transforming the Treatment of People Living with Cancer
    6. Progress in the Treatment of Multiple MyelomaPart I of Living with Multiple Myeloma
    7. Update from the 2021 American Society of Hematology (ASH) Annual Meeting
    8. Transplantation as a Treatment Option for Blood Cancers
    9. Update on CAR T-Cell Therapies
    10. Progress in the Treatment of Multiple Myeloma
    11. Adjusting to Your Blood Cancer Treatment Over Time: Challenges and Opportunities of Taking Your Treatment on Schedule
    12. Updates from the 2020 American Society of Hematology (ASH) Annual Meeting
    13. Progress in the Treatment of Multiple MyelomaPart I of Life with Multiple Myeloma
    14. Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
    15. Taking Your Blood Cancer Treatment on Schedule
    16. Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches

For Myelodysplastic Syndromes

    1. Progress in the Treatment of Myelodysplastic Syndromes (MDS)
    2. Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
    3. What’s New in Diagnostic Technologies for People Living with Blood CancersPart II of The Role of Diagnostic Technologies in Transforming the Treatment of People Living with Cancer
    4. Update from the 2021 American Society of Hematology (ASH) Annual Meeting
    5. Highlights from the 2021 American Society of Clinical Oncology (ASCO) Annual MeetingPart II of Equity. Every Patient. Every Day. Everywhere.
    6. Transplantation as a Treatment Option for Blood Cancers
    7. Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
    8. Update on CAR T-Cell Therapies
    9. Adjusting to Your Blood Cancer Treatment Over Time: Challenges and Opportunities of Taking Your Treatment on Schedule
    10. Updates from the 2020 American Society of Hematology (ASH) Annual Meeting
    11. Progress in the Treatment of Myelodysplastic Syndrome (MDS)
    12. Taking Your Blood Cancer Treatment on Schedule

For Myelofibrosis

    1. What’s New in Diagnostic Technologies for People Living with Blood CancersPart II of The Role of Diagnostic Technologies in Transforming the Treatment of People Living with Cancer
    2. Transplantation as a Treatment Option for Blood Cancers
    3. Progress in the Treatment of Myelofibrosis
    4. Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
    5. Update on CAR T-Cell Therapies
    6. Adjusting to Your Blood Cancer Treatment Over Time: Challenges and Opportunities of Taking Your Treatment on Schedule
    7. Updates from the 2020 American Society of Hematology (ASH) Annual Meeting
    8. Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
    9. Taking Your Blood Cancer Treatment on Schedule
    10. Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches

For Myeloproliferative Neoplasms

    1. Chronic Lymphocytic Leukemia (CLL): Treatment Updates
    2. Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
    3. What’s New in Diagnostic Technologies for People Living with Blood CancersPart II of The Role of Diagnostic Technologies in Transforming the Treatment of People Living with Cancer
    4. Update from the 2021 American Society of Hematology (ASH) Annual Meeting
    5. Highlights from the 2021 American Society of Clinical Oncology (ASCO) Annual MeetingPart II of Equity. Every Patient. Every Day. Everywhere.
    6. Transplantation as a Treatment Option for Blood Cancers
    7. Progress in the Treatment of Myelofibrosis
    8. Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
    9. Update on CAR T-Cell Therapies
    10. Progress in the Treatment of Waldenstrom’s Macroglobulinemia (WM)
    11. Adjusting to Your Blood Cancer Treatment Over Time: Challenges and Opportunities of Taking Your Treatment on Schedule
    12. Updates from the 2020 American Society of Hematology (ASH) Annual Meeting
    13. Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
    14. Taking Your Blood Cancer Treatment on Schedule
    15. Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches

For Non-Hodgkin Lymphoma

    1. Update On Marginal Zone Lymphoma (MZL)
    2. Waldenstrom’s Macroglobulinemia (WM): Treatment Progress
    3. Progress in the Treatment of Non-Hodgkin Lymphoma (NHL)
    4. Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
    5. Adjusting to Your Blood Cancer Treatment Over Time: Challenges and Opportunities of Taking Your Treatment on Schedule
    6. What’s New in Diagnostic Technologies for People Living with Blood CancersPart II of The Role of Diagnostic Technologies in Transforming the Treatment of People Living with Cancer
    7. Update from the 2021 American Society of Hematology (ASH) Annual Meeting
    8. Transplantation as a Treatment Option for Blood Cancers
    9. Progress in the Treatment of Non-Hodgkin Lymphoma (NHL)
    10. Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
    11. Update on CAR T-Cell Therapies
    12. Progress in the Treatment of Waldenstrom’s Macroglobulinemia (WM)
    13. Adjusting to Your Blood Cancer Treatment Over Time: Challenges and Opportunities of Taking Your Treatment on Schedule
    14. Progress in the Treatment of Follicular Lymphoma
    15. Updates from the 2020 American Society of Hematology (ASH) Annual Meeting
    16. Update on CAR-T Cell Therapy
    17. Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
    18. Progress in the Treatment of Non-Hodgkin Lymphoma (NHL)
    19. Taking Your Blood Cancer Treatment on Schedule
    20. Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
    21. The Emerging Role of Immunotherapy in the Treatment of Lymphoma

For Ovarian Cancer

    1. Highlights from the 2022 American Society of Clinical Oncology (ASCO) Annual Meeting – “Advancing Equitable Cancer Care Through Innovation"Part I of Highlights from the 2022 ASCO Annual Meeting
    2. Ovarian Cancer: Treatment Updates
    3. Highlights from the 2021 American Society of Clinical Oncology (ASCO) Annual MeetingPart I of Equity. Every Patient. Every Day. Everywhere.
    4. Medical Update on Ovarian Cancer
    5. Highlights from the 2020 American Society of Clinical Oncology (ASCO) Annual Meeting: Unite and Conquer: Accelerating Progress TogetherPart I of Your Guide to the Latest Cancer Research and Treatment

For Pancreatic Cancer

    1. Highlights from the 2022 American Society of Clinical Oncology (ASCO) Annual Meeting - "Advancing Equitable Cancer Care Through Innovation"Part II of Highlights from the 2022 ASCO Annual Meeting
    2. Highlights from the 2021 American Society of Clinical Oncology (ASCO) Annual MeetingPart II of Equity. Every Patient. Every Day. Everywhere.
    3. Treatment Update on Pancreatic Cancer

For Peripheral T-Cell Lymphoma

    1. Update On Marginal Zone Lymphoma (MZL)
    2. Waldenstrom’s Macroglobulinemia (WM): Treatment Progress
    3. Progress in the Treatment of Non-Hodgkin Lymphoma (NHL)
    4. Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
    5. Adjusting to Your Blood Cancer Treatment Over Time: Challenges and Opportunities of Taking Your Treatment on Schedule
    6. What’s New in Diagnostic Technologies for People Living with Blood CancersPart II of The Role of Diagnostic Technologies in Transforming the Treatment of People Living with Cancer
    7. Update from the 2021 American Society of Hematology (ASH) Annual Meeting
    8. Progress in the Treatment of Non-Hodgkin Lymphoma (NHL)
    9. Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
    10. Update on Diffuse Large B-Cell Lymphoma (DLBCL)
    11. Update on CAR T-Cell Therapies
    12. Progress in the Treatment of Waldenstrom’s Macroglobulinemia (WM)
    13. Adjusting to Your Blood Cancer Treatment Over Time: Challenges and Opportunities of Taking Your Treatment on Schedule
    14. Updates from the 2020 American Society of Hematology (ASH) Annual Meeting
    15. New Perspectives in the Treatment of Peripheral T-Cell Lymphoma (PTCL)
    16. Update on CAR-T Cell Therapy
    17. Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
    18. Taking Your Blood Cancer Treatment on Schedule
    19. Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
    20. The Emerging Role of Immunotherapy in the Treatment of Lymphoma

For Polycythemia Vera

    1. What’s New in Diagnostic Technologies for People Living with Blood CancersPart II of The Role of Diagnostic Technologies in Transforming the Treatment of People Living with Cancer
    2. Transplantation as a Treatment Option for Blood Cancers
    3. Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
    4. Update on CAR T-Cell Therapies
    5. Adjusting to Your Blood Cancer Treatment Over Time: Challenges and Opportunities of Taking Your Treatment on Schedule
    6. Updates from the 2020 American Society of Hematology (ASH) Annual Meeting
    7. Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
    8. Taking Your Blood Cancer Treatment on Schedule
    9. Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
    10. The Emerging Role of Immunotherapy in the Treatment of Lymphoma

For Prostate Cancer

    1. Highlights from the 2022 American Society of Clinical Oncology (ASCO) Annual Meeting – “Advancing Equitable Cancer Care Through Innovation"Part I of Highlights from the 2022 ASCO Annual Meeting
    2. Metastatic Prostate Cancer: Treatment AdvancesPart I of Living with Metastatic Prostate Cancer
    3. Highlights from the 2021 American Society of Clinical Oncology (ASCO) Annual MeetingPart I of Equity. Every Patient. Every Day. Everywhere.
    4. Advances in the Treatment of Metastatic Prostate Cancer
    5. Highlights from the 2020 American Society of Clinical Oncology (ASCO) Annual Meeting: Unite and Conquer: Accelerating Progress TogetherPart I of Your Guide to the Latest Cancer Research and Treatment

For Renal Cell Cancer

    1. Renal Cell Cancer: Treatment Advances
    2. Advances in the Treatment of Renal Cell Cancer

For Sarcoma

    1. Highlights from the 2022 American Society of Clinical Oncology (ASCO) Annual Meeting – “Advancing Equitable Cancer Care Through Innovation"Part I of Highlights from the 2022 ASCO Annual Meeting
    2. People of Color Living with Skin Cancer
    3. Highlights from the 2021 American Society of Clinical Oncology (ASCO) Annual MeetingPart I of Equity. Every Patient. Every Day. Everywhere.
    4. Highlights from the 2020 American Society of Clinical Oncology (ASCO) Annual Meeting: Unite and Conquer: Accelerating Progress TogetherPart I of Your Guide to the Latest Cancer Research and Treatment
    5. Update on Soft Tissue Sarcoma
    6. Update on Rare Sarcomas

For Skin Cancer

    1. People of Color Living with Skin Cancer
    2. Emerging Treatments for Metastatic MelanomaPart II of Living with Advanced Skin Cancer and Melanoma
    3. Emerging Treatments for Metastatic MelanomaPart II of Living with Advanced Skin Cancer and Melanoma
    4. New Perspectives in the Treatment of Advanced Skin Cancer: Advanced Basal Cell and Squamous Cell CancersPart I of Living with Advanced Skin Cancer and Melanoma
    5. New Perspectives in the Treatment of Advanced Skin Cancer: Advanced Basal Cell and Squamous Cell Cancers
    6. Emerging Treatments for Metastatic MelanomaPart II of Life with Advanced Skin Cancer
    7. New Perspectives in the Treatment of Advanced Skin Cancer: Advanced Basal Cell and Squamous Cell CancersPart I of Life with Advanced Skin Cancer
    8. Treatment Perspectives on Merkel Cell Carcinoma (MCC)Part I of Living with Merkel Cell Carcinoma (MCC)

For Small Lymphocytic Lymphoma

    1. Update On Marginal Zone Lymphoma (MZL)
    2. Waldenstrom’s Macroglobulinemia (WM): Treatment Progress
    3. Progress in the Treatment of Non-Hodgkin Lymphoma (NHL)
    4. Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
    5. Adjusting to Your Blood Cancer Treatment Over Time: Challenges and Opportunities of Taking Your Treatment on Schedule
    6. What’s New in Diagnostic Technologies for People Living with Blood CancersPart II of The Role of Diagnostic Technologies in Transforming the Treatment of People Living with Cancer
    7. Update from the 2021 American Society of Hematology (ASH) Annual Meeting
    8. Transplantation as a Treatment Option for Blood Cancers
    9. Progress in the Treatment of Non-Hodgkin Lymphoma (NHL)
    10. Update on CAR T-Cell Therapies
    11. Adjusting to Your Blood Cancer Treatment Over Time: Challenges and Opportunities of Taking Your Treatment on Schedule
    12. Updates from the 2020 American Society of Hematology (ASH) Annual Meeting
    13. Update on CAR-T Cell Therapy
    14. Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
    15. Taking Your Blood Cancer Treatment on Schedule
    16. Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches